Turning Point Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (2013)

Organization Overview

First Clinical Trial
2016
NCT03154619
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

TR Therapeutics, Inc. | Turning Point | Turning Point Theraperutics | Turning Point Therapeutics | Turning Point Therapeutics, Inc.